Relationship of driver oncogenes to long term pemetrexed response in non-small cell lung cancer

BACKGROUND: Pemetrexed is approved in the treatment of advanced stage non-squamous non-small-cell lung cancer (NSCLC). The length of response is variable, and we thus sought to identify which clinicopathologic characteristics are associated with long term disease control with pemetrexed. METHODS: Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Ying, Wakelee, Heather A., Neal, Joel W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490141/
https://www.ncbi.nlm.nih.gov/pubmed/25665893
http://dx.doi.org/10.1016/j.cllc.2014.12.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490141/
https://www.ncbi.nlm.nih.gov/pubmed/25665893
http://dx.doi.org/10.1016/j.cllc.2014.12.009

Ejemplares similares